Highlights and Quick Summary
- Cash and Short Term Investments for the quarter ending June 30, 2022 was $1.82 Million (a -69.43% decrease compared to previous quarter)
- Year-over-year quarterly Cash and Short Term Investments decreased by -95.0%
- Annual Cash and Short Term Investments for 2021 was $8.24 Million (a -3.38% decrease from previous year)
- Annual Cash and Short Term Investments for 2021 was $8.53 Million (a -56.28% decrease from previous year)
- Annual Cash and Short Term Investments for 2020 was $19.5 Million (a 4.93% increase from previous year)
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Cash and Short Term Investments of Biofrontera AG Sponsored ADR
Most recent Cash and Short Term Investmentsof BFAGY including historical data for past 10 years.Interactive Chart of Cash and Short Term Investments of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR Cash and Short Term Investments for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | $1.82 | $5.96 | – |
| 2021 | $7.85 | $36.45 | $40.6 | $45.87 | $8.24 |
| 2020 | $20.43 | $20.14 | $11.85 | $9.42 | $19.51 |
| 2019 | – | $12.49 | $26.72 | $25.44 | $13.66 |
| 2018 | – | – | – | $25.51 | $23.91 |
| 2017 | – | – | $16.83 | $17.75 | $13.17 |
| 2016 | $18.25 | – | – | – | $18.26 |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic